ESC outlines key asks in its response to the Commission’s Call for Evidence on the EU Cardiovascular Health Plan
As part of the European Commission’s process to consult stakeholders and gather views on the upcoming EU Cardiovascular Health (CVH) Plan, the European Society of Cardiology (ESC) submitted its response…
Cuore: studio italiano rivoluziona standard di cura post-angioplastica
Un nuovo studio italiano rivoluziona lo standard di cura dei pazienti che hanno subito un’angioplastica coronarica, dimostrando sicurezza ed efficacia di un approccio farmacologico personalizzato. Il team di ricerca tutto…
The CORE-MD consortium publishes landmark recommendations for clinical investigations of high-risk medical devices in Europe
The CORE-MD (Coordinating Research and Evidence for high-risk Medical Devices) consortium is publishing new consensus recommendations today in The Lancet Regional Health Europe , that set out scientifically robust methodologies…
Increasing potassium levels improve outcomes in patients at high risk of ventricular arrhythmia #ESCCongress #ESC25
Targeting high-normal potassium levels reduced the risk of arrhythmias, hospitalisation for heart failure or arrhythmia and death compared with no intervention, according to late-breaking research presented in a Hot Line…
No significant reduction in death following an invitation to undergo comprehensive cardiovascular screening in men aged 60 to 64 years #ESCCongress #ESC25
An invitation to attend a comprehensive screening examination for the early signs of cardiovascular disease (CVD) did not reduce all-cause death among men aged 60 to 64 years, according to…
#ESC25 calls for a cultural shift to deal with the adverse combination of mental health conditions and cardiovascular disease #ESCCongress
A new ESC Clinical Consensus Statement is calling for greater awareness of the multidirectional relationship between mental health conditions and cardiovascular disease to improve patient health. The first ever ESC…
I defibrillatori cardioverter impiantabili non hanno migliorato la mortalità in pazienti selezionati con infarto e marcatori del ritmo cardiaco anormali #ESCCongress #ESC25
La terapia profilattica con defibrillatore cardioverter impiantabile non ha ridotto la mortalità nei pazienti con pregresso infarto del miocardio, disfunzione sistolica ventricolare sinistra moderata persistente e marcatori ECG anomali, secondo…
GRAVIDANZA, TEAM CARDIOLOGICI PER LE TERAPIE CORRETTE ANCHE AD ALTO RISCHIO. LINEE GUIDA #ESC25 #EscCongress
Le linee guida aggiornate ESC 2025 pongono al centro l’autonomia decisionale delle donne con patologie cardiovascolari in gravidanza, promuovendo un dialogo trasparente e un processo condiviso nelle scelte riproduttive. Le…
La musica che regola il cuore e la pressione. Congresso europeo a Madrid #ESCCongress #ESC25
Un nuovo studio mostra che la pressione sanguigna si sincronizza con la musica prevedibile. La scoperta apre la strada a future terapie cardiovascolari. Un team di ricercatori, guidato da Elaine…
Older age and low fitness levels are associated with heartbeat abnormalities that increase future cardiovascular risk #ESCCongress #ESC25 in Madrid
New research has revealed that older age and low aerobic fitness levels are strong and independent risk factors for a high burden of heartbeat irregularities, known as arrhythmias*, that indicate…